2022.01
Genomeweb | Genecast Minimal Residual Disease Test Plans Bolstered by New Lung Cancer Data
Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
2019.10
Genecast Biotechnology Receives ¥300 Million in Series D1 Financing
Genecast Biotechnology Receives ¥300 Million in Series D1 Financing
2019.09
Genecast Biotechnology Wins “EY Fudan China the Most Promising Enterprises Award”
Genecast Biotechnology Wins “EY Fudan China the Most Promising Enterprises Award”
2019.09
Genecast Biotechnology Obtains Qualification for NGS Detection
Genecast Biotechnology Obtains Qualification for NGS Detection
2019.08
AstraZeneca and Genecast Biotechnology Sign Agreement for Strategic Cooperation in Precision Medicine
AstraZeneca and Genecast Biotechnology Sign Agreement for Strategic Cooperation in Precision Medicine
12345